INTERNATIONAL PATENT: IDORSIA PHARMACEUTICALS LTD FILES APPLICATION FOR "ARYL SULFONE AND SULFANONE DERIVATIVES AS OREXIN RECEPTOR MODULATORS"

GENEVA, June 23 -- IDORSIA PHARMACEUTICALS LTD (Hegenheimermattweg 914123 Allschwil) filed a patent application (PCT/EP2023/085388) for "ARYL SULFONE AND SULFANONE DERIVATIVES AS OREXIN RECEPTOR MODULATORS" on Dec 12, 2023. With publication no. WO/2025/124698, the details related to the patent application was published on Jun 19, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): AISSAOUI, Hamed (c/o Idorsia Pharmaceuticals Ltd Hegenheimermattweg 914123 Allschwil), BEZENCON, Olivier (c/o Idorsia Pharmaceuticals Ltd Hegenheimermattweg 914123 Allschwil), HEIDMANN, Bibia (c/o Idorsia Pharmaceutica...